Genome Editing Market To Reach $10.1 Billion By 2026 With CAGR: 14.8% | Reports And Data
An extensive study of the product application and services conducted by subject matter experts assessing the Genome Editing Market will help product owners to make a wise decision.
New York, United States – July 1, 2020 /MarketersMedia/ —
The market is driven by the increasing incidence of genetic diseases, favorable funding scenario for research & development in the field of genetic engineering, technological advancements in genetic engineering such as developments in CRISPR technology, increasing focus of food industry on genetically modified organisms, and rising awareness about efficacy as well applications of genetic engineering methods. For instance, globally over 175 million hectares of land is used for GM crops production. However, stringent regulatory scenario and ethical concerns for gene editing research and applications and concerns among end users regarding use of gene alteration therapies are likely to hinder the market growth during the forecast period.
This is the latest report covering the current COVID-19 scenario. The coronavirus pandemic has greatly affected every aspect of the worldwide industry. It has brought along various changes in market conditions. The rapidly changing market scenario and initial and future assessment of the impact are covered in the research report. The report discusses all the major aspects of the market with expert opinions on the current status along with historical data.
Get your copy of the sample of the global Genome Editing industry report @ https://www.reportsanddata.com/sample-enquiry-form/1052
Key participants include Thermo Fisher Scientific Inc., Merck KGaA, GenScript, Horizon Discovery Group Plc, Integrated DNA Technologies, Inc, Lonza, New England Biolabs and Sangamo Therapeutics, Inc..
For the purpose of this report, Reports and Data has segmented the Genetic Editing market on the basis of type, application, end user and region:
Type Outlook (Revenue, USD Million, 2016 – 2026)
• Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
• Transcription Activator-Like Effector Nucleases (TALEN)
• Zinc Finger Nucleases (ZFN)
• Others
Application Outlook (Revenue, USD Million, 2016 – 2026)
• Animal Genetic Engineering
• Therapeutic Application
• Genetically Modified Organisms
• Plant Genetic Engineering
• Cell Line Engineering
End User Outlook (Revenue, USD Million, 2016 – 2026)
• Pharma-Biotech Companies
• Academic Institutes & Research Center
• Agrigenomic Companies
• Contract Research Organizations
Get a discount on your copy of the report @ https://www.reportsanddata.com/discount-enquiry-form/1052
Regional Outlook (Revenue in USD Million; 2016–2026)
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Further key findings from the report suggest
• CRISPR market is rising at a high growth rate of 30.9 percent in Asia Pacific followed by North America and Europe. Rising application of genetic engineering for therapeutics will drive the demand for the market during forecast period across all regions.
• The valuation for TALEN market was USD 1.79 billion in 2018 and is expected to grow to USD 2.01 billion by 2026. Benefits associated with TALEN high degrees of precision and control, is the key factor supporting the wide-scale adoption of the technology and consequently contributing to the market growth.
• Asia Pacific is expected to witness a CAGR of 15.8 percent in the forecast period. Emerging markets such China and Japan are likely to witness high growth
• Regional regulatory approval is another key regulatory factor for adoption and growth of genetic editing in the region.
Key questions addressed in the Genome Editing market:
1. What are the current trends that are dictating the growth of the Genome Editing market?
2. What is the scope of innovation in the current market landscape?
3. How will the recent amendments in the industrial policies in the regions affect the growth of the Genome Editing market?
4. What is the projected value of the market in 2026?
5. Which regional market is expected to witness the highest CAGR growth during the assessment period?
Browse Complete Report @ https://www.reportsanddata.com/report-detail/genome-editing-market
Thank you for reading our report. For further details or to inquire about customization, please let us know and we will offer you the report as per your needs.
About Us:
Our in-house experts assist our clients with advice based on their proficiency in the market that helps them in creating a compendious database for the clients. Our team offers expert insights to clients to guide them through their business ventures. We put in rigorous efforts to keep our clientele satisfied and focus on fulfilling their demands to make sure that the end-product is what they desire. We excel in diverse fields of the market and with our services extending to competitive analysis, research and development analysis, and demand estimation among others, we can help you invest your funds in the most beneficial areas for research and development. You can rely on us to provide every significant detail you might need in your efforts to make your business flourish.
Contact Info:
Name: John Watson
Email: Send Email
Organization: Reports And Data
Address: 40 Wall St. 28th floor New York City, NY 10005 United States
Phone: +1-212-710-1370
Website: https://www.reportsanddata.com/
Source: MarketersMedia
Release ID: 88966743
Copyright © 1999-2013 SproutNews.com
